SPSB1 (FDR adjusted P < 0.0003) has been found as a novel regulator of the transforming growth factor-β (TGF-β) signaling pathway [24], which mediates fibrosis and plays an important role in CKD [25]. Here, TGFB1 is linked to chronic kidney disease.